@prefix nt: .
@prefix this: .
@prefix sub: .
@prefix drugbank: .
@prefix np: .
@prefix mondo: .
@prefix pav: .
@prefix infores: .
@prefix xsd: .
@prefix orcid: .
@prefix rdfs: .
@prefix pmid: .
@prefix ncit: .
@prefix rdf: .
@prefix biolink: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
drugbank:DB01221 a biolink:Drug;
rdfs:label "Ketamine";
biolink:category biolink:Drug .
mondo:0005146 a biolink:Disease;
rdfs:label "Post-traumatic stress disorder";
biolink:category biolink:Disease .
sub:association a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
rdf:object mondo:0005146;
rdf:predicate biolink:treats;
rdf:subject drugbank:DB01221;
rdfs:label "Off-label and novel treatments continue to be considered for more refractory and disabling cases of PTSD.";
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
biolink:has_population_context sub:context;
biolink:publications pmid:31007698;
biolink:relation ncit:C94303 .
sub:context a biolink:Cohort;
rdfs:label "Adults";
biolink:category biolink:Cohort .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
npx:hasSignature "eg6Vnphs38fOqN2zfn+xcga4N+0zvQi+K6visl5kRMua0L7rbXijksAic9JZdzxhw7BG8PrEepgRHNepZViGLvXqSv928oSw/ccPtp6UmWALK5o3UN0qUB6KkNgx6xFYNY7yrSFJAlv2cQuIVBN/IM7eJU7+ogCMOCLGnWdIE5c=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-09-16T11:51:21.261623"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-1501-1082;
nt:wasCreatedFromTemplate .
biolink: pav:version "2.3.0" .
}